Cargando…

Comparative analysis of targeted next-generation sequencing for Plasmodium falciparum drug resistance markers

Well-defined molecular resistance markers are available for a range of antimalarial drugs, and molecular surveillance is increasingly important for monitoring antimalarial drug resistance. Different genotyping platforms are available, but these have not been compared in detail. We compared Targeted...

Descripción completa

Detalles Bibliográficos
Autores principales: Kunasol, Chanon, Dondorp, Arjen M., Batty, Elizabeth M., Nakhonsri, Vorthunju, Sinjanakhom, Puritat, Day, Nicholas P. J., Imwong, Mallika
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8974807/
https://www.ncbi.nlm.nih.gov/pubmed/35365711
http://dx.doi.org/10.1038/s41598-022-09474-5
_version_ 1784680280118788096
author Kunasol, Chanon
Dondorp, Arjen M.
Batty, Elizabeth M.
Nakhonsri, Vorthunju
Sinjanakhom, Puritat
Day, Nicholas P. J.
Imwong, Mallika
author_facet Kunasol, Chanon
Dondorp, Arjen M.
Batty, Elizabeth M.
Nakhonsri, Vorthunju
Sinjanakhom, Puritat
Day, Nicholas P. J.
Imwong, Mallika
author_sort Kunasol, Chanon
collection PubMed
description Well-defined molecular resistance markers are available for a range of antimalarial drugs, and molecular surveillance is increasingly important for monitoring antimalarial drug resistance. Different genotyping platforms are available, but these have not been compared in detail. We compared Targeted Amplicon Deep sequencing (TADs) using Ion Torrent PGM with Illumina MiSeq for the typing of antimalarial drug resistance genes. We developed and validated protocols to type the molecular resistance markers pfcrt, pfdhfr, pfdhps, pfmdr1, pfkelch, and pfcytochrome b, in Plasmodium falciparum for the Ion Torrent PGM and Illumina MiSeq sequencing platforms. With P. falciparum 3D7 and K1 as reference strains, whole blood samples (N = 20) and blood spots from Rapid Diagnostic Test (RDT) samples (N = 5) from patients with uncomplicated falciparum malaria from Ubon Ratchathani were assessed on both platforms and compared for coverage (average reads per amplicon), sequencing accuracy, variant accuracy, false positive rate, false negative rate, and alternative allele detection, with conventional Sanger sequencing as the reference method for SNP calling. Both whole blood and RDT samples could be successfully sequenced using the Ion Torrent PGM and Illumina MiSeq platforms. Coverage of reads per amplicon was higher with Illumina MiSeq (28,886 reads) than with Ion Torrent PGM (1754 reads). In laboratory generated artificial mixed infections, the two platforms could detect the minor allele down to 1% density at 500X coverage. SNPs calls from both platforms were in complete agreement with conventional Sanger sequencing. The methods can be multiplexed with up to 96 samples per run, which reduces cost by 86% compared to conventional Sanger sequencing. Both platforms, using the developed TAD protocols, provide an accurate method for molecular surveillance of drug resistance markers in P. falciparum, but Illumina MiSeq provides higher coverage than Ion Torrent PGM.
format Online
Article
Text
id pubmed-8974807
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-89748072022-04-04 Comparative analysis of targeted next-generation sequencing for Plasmodium falciparum drug resistance markers Kunasol, Chanon Dondorp, Arjen M. Batty, Elizabeth M. Nakhonsri, Vorthunju Sinjanakhom, Puritat Day, Nicholas P. J. Imwong, Mallika Sci Rep Article Well-defined molecular resistance markers are available for a range of antimalarial drugs, and molecular surveillance is increasingly important for monitoring antimalarial drug resistance. Different genotyping platforms are available, but these have not been compared in detail. We compared Targeted Amplicon Deep sequencing (TADs) using Ion Torrent PGM with Illumina MiSeq for the typing of antimalarial drug resistance genes. We developed and validated protocols to type the molecular resistance markers pfcrt, pfdhfr, pfdhps, pfmdr1, pfkelch, and pfcytochrome b, in Plasmodium falciparum for the Ion Torrent PGM and Illumina MiSeq sequencing platforms. With P. falciparum 3D7 and K1 as reference strains, whole blood samples (N = 20) and blood spots from Rapid Diagnostic Test (RDT) samples (N = 5) from patients with uncomplicated falciparum malaria from Ubon Ratchathani were assessed on both platforms and compared for coverage (average reads per amplicon), sequencing accuracy, variant accuracy, false positive rate, false negative rate, and alternative allele detection, with conventional Sanger sequencing as the reference method for SNP calling. Both whole blood and RDT samples could be successfully sequenced using the Ion Torrent PGM and Illumina MiSeq platforms. Coverage of reads per amplicon was higher with Illumina MiSeq (28,886 reads) than with Ion Torrent PGM (1754 reads). In laboratory generated artificial mixed infections, the two platforms could detect the minor allele down to 1% density at 500X coverage. SNPs calls from both platforms were in complete agreement with conventional Sanger sequencing. The methods can be multiplexed with up to 96 samples per run, which reduces cost by 86% compared to conventional Sanger sequencing. Both platforms, using the developed TAD protocols, provide an accurate method for molecular surveillance of drug resistance markers in P. falciparum, but Illumina MiSeq provides higher coverage than Ion Torrent PGM. Nature Publishing Group UK 2022-04-01 /pmc/articles/PMC8974807/ /pubmed/35365711 http://dx.doi.org/10.1038/s41598-022-09474-5 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Kunasol, Chanon
Dondorp, Arjen M.
Batty, Elizabeth M.
Nakhonsri, Vorthunju
Sinjanakhom, Puritat
Day, Nicholas P. J.
Imwong, Mallika
Comparative analysis of targeted next-generation sequencing for Plasmodium falciparum drug resistance markers
title Comparative analysis of targeted next-generation sequencing for Plasmodium falciparum drug resistance markers
title_full Comparative analysis of targeted next-generation sequencing for Plasmodium falciparum drug resistance markers
title_fullStr Comparative analysis of targeted next-generation sequencing for Plasmodium falciparum drug resistance markers
title_full_unstemmed Comparative analysis of targeted next-generation sequencing for Plasmodium falciparum drug resistance markers
title_short Comparative analysis of targeted next-generation sequencing for Plasmodium falciparum drug resistance markers
title_sort comparative analysis of targeted next-generation sequencing for plasmodium falciparum drug resistance markers
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8974807/
https://www.ncbi.nlm.nih.gov/pubmed/35365711
http://dx.doi.org/10.1038/s41598-022-09474-5
work_keys_str_mv AT kunasolchanon comparativeanalysisoftargetednextgenerationsequencingforplasmodiumfalciparumdrugresistancemarkers
AT dondorparjenm comparativeanalysisoftargetednextgenerationsequencingforplasmodiumfalciparumdrugresistancemarkers
AT battyelizabethm comparativeanalysisoftargetednextgenerationsequencingforplasmodiumfalciparumdrugresistancemarkers
AT nakhonsrivorthunju comparativeanalysisoftargetednextgenerationsequencingforplasmodiumfalciparumdrugresistancemarkers
AT sinjanakhompuritat comparativeanalysisoftargetednextgenerationsequencingforplasmodiumfalciparumdrugresistancemarkers
AT daynicholaspj comparativeanalysisoftargetednextgenerationsequencingforplasmodiumfalciparumdrugresistancemarkers
AT imwongmallika comparativeanalysisoftargetednextgenerationsequencingforplasmodiumfalciparumdrugresistancemarkers